OVID
Ovid Therapeutics Inc
2.50$
+5.1%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.3% | -66.1% | +8.8% | +14.2% | -13.0% | -4.1% | -29.8% | -82.8% | +0.0% | +105.9% | -54.3% | – | |
| – | +9.7% | +10.0% | -11.6% | -24.8% | -3.7% | +1.9% | -5.1% | -9.0% | +7.8% | -12.5% | +36.8% | – | |
| – | +12,505.0% | -147.6% | – | -141.7% | – | – | – | – | – | +1,640.3% | -191.2% | – | |
| – | -76.8% | +1,462.5% | +78.9% | -88.2% | +450.0% | +0.0% | -100.0% | – | – | – | – | – | |
| – | +1,012.9% | – | -36.5% | -97.7% | +7,191.8% | -76.0% | +136.2% | -58.1% | -1,526.1% | – | -1,557.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +13,324.6% | -99.2% | +56.1% | -89.3% | -100.0% | – | -100.0% | – | +501,093.3% | +18.4% | -75.7% | – | |
| – | – | – | -128.9% | – | – | -145.8% | – | -207.2% | – | – | -202.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.